Biodesix to Provide COVID-19 Testing for Colorado State University Campus

Biodesix Prepares to Test Thousands as Students Return to Campus

BOULDER, CO, August 12, 2020 – Biodesix, Inc., a leading diagnostic company with a focus in lung disease, today announced plans to provide COVID-19 ddPCR diagnostic testing for Colorado State University (CSU) as students return to campus for the fall term, which begins August 24. “The health and safety of our nation’s students, and the faculty and staff that teach, guide, and mentor them, is of utmost importance to us. We are pleased to be able to support CSU in their efforts to help navigate a return to campus during this global pandemic,” said Scott Hutton, CEO of Biodesix. 

Learn more in the press release.

Categories: Ecosystem News